BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

984 related articles for article (PubMed ID: 23523416)

  • 1. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences.
    van den Broek FJ; Stokkers PC; Reitsma JB; Boltjes RP; Ponsioen CY; Fockens P; Dekker E
    Am J Gastroenterol; 2014 May; 109(5):715-22. PubMed ID: 21427710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
    Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU; Broomé U; Persson B
    Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitis.
    Kaplan GG; Heitman SJ; Hilsden RJ; Urbanski S; Myers RP; Lee SS; Burak KW; Swain M; Panaccione R
    Inflamm Bowel Dis; 2007 Nov; 13(11):1401-7. PubMed ID: 17600816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Venkatesh PG; Lashner BA; Remzi FH; Shen B; Kiran RP
    J Crohns Colitis; 2012 Sep; 6(8):845-51. PubMed ID: 22398080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting dysplasia using white light endoscopy or chromoendoscopy in ulcerative colitis patients without primary sclerosing cholangitis: A systematic review and meta-analysis.
    Azizi S; Al-Rubaye H; Turki MAA; Siddiqui MRS; Shanmuganandan AP; Ehsanullah B; Brar R; Abulafi AM
    Int J Surg; 2018 Apr; 52():180-188. PubMed ID: 29462738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yield of Random Biopsies During Colonoscopies in Inflammatory Bowel Disease Patients Undergoing Dysplasia Surveillance.
    Hu AB; Burke KE; Kochar B; Ananthakrishnan AN
    Inflamm Bowel Dis; 2021 May; 27(6):779-786. PubMed ID: 32812048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
    Moussata D; Allez M; Cazals-Hatem D; Treton X; Laharie D; Reimund JM; Bertheau P; Bourreille A; Lavergne-Slove A; Brixi H; Branche J; Gornet JM; Stefanescu C; Moreau J; Marteau P; Pelletier AL; Carbonnel F; Seksik P; Simon M; Fléjou JF; Colombel JF; Charlois AL; Roblin X; Nancey S; Bouhnik Y; Berger F; Flourié B;
    Gut; 2018 Apr; 67(4):616-624. PubMed ID: 28115492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.
    Korelitz BI; Sultan K; Kothari M; Arapos L; Schneider J; Panagopoulos G
    World J Gastroenterol; 2014 May; 20(17):4980-6. PubMed ID: 24803809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
    Krugliak Cleveland N; Rubin DT; Hart J; Weber CR; Meckel K; Tran AL; Aelvoet AS; Pan I; Gonsalves A; Gaetano JN; Williams KM; Wroblewski K; Jabri B; Pekow J
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):68-74. PubMed ID: 28756053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?
    Blonski W; Kundu R; Lewis J; Aberra F; Osterman M; Lichtenstein GR
    Scand J Gastroenterol; 2008; 43(6):698-703. PubMed ID: 18569987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.
    Broomé U; Löfberg R; Lundqvist K; Veress B
    Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
    Eaton JE; Smyrk TC; Imam M; Pardi DS; Loftus EV; Owens VL; Talwalkar JA
    Aliment Pharmacol Ther; 2013 Oct; 38(8):977-87. PubMed ID: 24033551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Brentnall TA; Haggitt RC; Rabinovitch PS; Kimmey MB; Bronner MP; Levine DS; Kowdley KV; Stevens AC; Crispin DA; Emond M; Rubin CE
    Gastroenterology; 1996 Feb; 110(2):331-8. PubMed ID: 8566577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.